5.660SEK+9209.21%Mkt Cap: 149.20M SEKP/E: —Last update: 2026-06-03
Active Biotech AB (publ), a biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden. It is developing Tasquinimod, a small m…
Industry Peers
Biotechnology108.72BUSDP/E 25.5
93.56BDKKP/E 18.0
64.89BUSDP/E 15.1
47.95BEURP/E 31.4
43.25BEURP/E 35.9
39.06BUSDP/E 73.5
33.16BUSD—
31.65BUSDP/E 28.9
Indicators:|
Key Statistics
Company
Market Cap149.20M SEK
Enterprise Value102.18M SEK
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-37.32M SEK
Revenue/Share—
Last Price5.660 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees5
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG0.13
EV/EBITDA-2.84
EV/Revenue—
P/S—
P/B2.99
EPS (TTM)-0.02
EPS (Forward)0.00
52W Range
0.037093% of range6.080
52W High6.080 SEK
52W Low0.0370 SEK
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-67.11%
ROA-53.16%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-32.40M SEK
CapEx (TTM)—
FCF Margin—
FCF Yield-4.71%
Net Debt-63.36M SEK
Net Debt/EBITDA1.76
Balance Sheet
Debt/Equity0.03
Current Ratio4.67
Quick Ratio4.59
Book Value/Sh0.0210 SEK
Cash/Share0.0250 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateJun 3, 2026
Analyst Consensus
Rating—
Target (Mean)0.2500 SEK
Target Range0.2500 SEK – 0.2500 SEK
# Analysts1
Ownership
Shares Out.2.64B
Float2.05B
Insiders39.59%
Institutions10.37%
Technical
SMA 500.0632 (+8858.0%)
SMA 2000.0785 (+7107.9%)
Beta1.33
S&P 52W Chg27.70%
Avg Vol (30d)25.14M
Avg Vol (10d)36.25M
Technical Indicators
RSI (14)99.7
MACD0.4466
MACD Signal0.0906
MACD Hist.+0.3560
BB Upper2.847 SEK
BB Middle0.3455 SEK
BB Lower-2.1564 SEK
BB Width1448.44%
ATR (14)0.4357 SEK
Vol Ratio (20d)0.01x